134 related articles for article (PubMed ID: 3501425)
1. Roxithromycin alone and in combination with sulphamethoxazole against Haemophilus influenzae.
Lapointe JR; Lavallée C; Meilleur R; Bourget C
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():21-9. PubMed ID: 3501425
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
Jorgensen JH; Redding JS; Howell AW
Antimicrob Agents Chemother; 1986 May; 29(5):921-2. PubMed ID: 3488019
[TBL] [Abstract][Full Text] [Related]
3. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
Lapointe JR; Lavallée C
J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
[TBL] [Abstract][Full Text] [Related]
5. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Bergeron MG; Lavoie GY; Boucher FD
J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
[TBL] [Abstract][Full Text] [Related]
6. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
8. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae.
Goldstein FW; Emirian MF; Coutrot A; Acar JF
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():25-8. PubMed ID: 2154434
[TBL] [Abstract][Full Text] [Related]
9. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
Sinai R; Hammerberg S; Marks MI; Pai CH
Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
12. Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986.
Powell M; Koutsia-Carouzou C; Voutsinas D; Seymour A; Williams JD
Br Med J (Clin Res Ed); 1987 Jul; 295(6591):176-9. PubMed ID: 3115364
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
Kirven LA; Thornsberry C
Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
[TBL] [Abstract][Full Text] [Related]
14. Spiramycin alone and in combination with trimethoprim against Haemophilus influenzae.
Arditi M; Yogev R
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():57-62. PubMed ID: 3263355
[TBL] [Abstract][Full Text] [Related]
15. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
Dubreuil L
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of roxithromycin against respiratory and skin pathogens.
Pechére JC; Auckenthaler R
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
19. Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.
Kirven LA; Thornsberry C
Antimicrob Agents Chemother; 1978 Nov; 14(5):731-6. PubMed ID: 310281
[TBL] [Abstract][Full Text] [Related]
20. High nasopharyngeal carriage of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae in north Indian school-going children.
Jain A; Kumar P; Agarwal SK
J Infect Chemother; 2008 Feb; 14(1):72-4. PubMed ID: 18297455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
